Drug General Information (ID: DDIP7T8FNA)
Drug Name			Liotrix		Drug Info		Linaclotide		Drug Info
Drug Type		Small molecule				Small molecule
Therapeutic Class		Thyroid Drugs				Guanylate Cyclase-C Agonists
Structure

Mechanism of Liotrix-Linaclotide Interaction (Severity Level: Moderate)
Altered absorption (Unspecific) Click to Show/Hide Mechanism Graph
Drug Name		Liotrix				Linaclotide
Mechanism		Absorption decreased by vomiting/diarrhea-causing agents				Vomiting/diarrhea-causing agent
Key Mechanism Factor 1
		Factor Name		Pharmacokinetic
		Factor Description		Alters the absorption of the drug, leading to changes in the plasma concentration of the drug and affecting the pharmacological effects.
Mechanism Description		Altered absorption of Liotrix caused by Linaclotide

Recommended Action
Management		Caution and monitoring for altered efficacy is recommended during concomitant use.

References
1	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
2	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".